Gayatri Bioorganics Ltd vs Prima Innovation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 31, 2026

Key Highlights

The Latest Trading Price of Gayatri BioOrganics Ltd is ₹ 8 as of 30 Oct 15:30 . The P/E Ratio of Gayatri BioOrganics Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Prima Innovation Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Gayatri BioOrganics Ltd changed from ₹ 50.74 crore on March 2021 to ₹ 108.89 crore on March 2026 . This represents a CAGR of 13.57% over 6 yearsThe Market Cap of Prima Innovation Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 years The revenue of Gayatri BioOrganics Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 2.34 crore. This represent the decline of -100% The revenue of Prima Innovation Ltd for the Sep '26 is ₹ 19.45 crore as compare to the Jun '26 revenue of ₹ 15.36 crore. This represent the growth of 26.63% The ebitda of Gayatri BioOrganics Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0.01 crore. This represent the decline of -100% The ebitda of Prima Innovation Ltd for the Sep '26 is ₹ 1.24 crore as compare to the Jun '26 ebitda of ₹ 1.69 crore. This represent the decline of -26.63% The net profit of Gayatri BioOrganics Ltd changed from ₹ -0.21 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Prima Innovation Ltd changed from ₹ -0.55 crore to ₹ 0.08 crore over 6 quarters. This represents a CAGR of NaN% The Dividend Payout of Gayatri BioOrganics Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Prima Innovation Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Gayatri BioOrganics Ltd

Gayatri BioOrganics Limited was initially incorporated as 'Starchem Industries Limited' on December 2, 1991.
Later on, the name was changed to Gayatri Starchem Limited on 24 October, 1997.
On 13th February, 2008, the name was further changed to Gayatri BioOrganics Limited.
It was promoted jointly by T V Sandeep Reddy and D S P Reddy and Associates. Gayatri BioOrganics Limited is one of the largest manufacturing units of Starch, Modified Starches, Liquid Glucose, Sorbitol, and its allied products and trading in Maize in South India.
The Company has manufacturing plants located in states of Karnataka and Telangana.

FAQs for the comparison of Gayatri BioOrganics Ltd and Prima Innovation Ltd

Which company has a larger market capitalization, Gayatri BioOrganics Ltd or Prima Innovation Ltd?

Market cap of Gayatri BioOrganics Ltd is 63 Cr while Market cap of Prima Innovation Ltd is 27 Cr

What are the key factors driving the stock performance of Gayatri BioOrganics Ltd and Prima Innovation Ltd?

The stock performance of Gayatri BioOrganics Ltd and Prima Innovation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Gayatri BioOrganics Ltd and Prima Innovation Ltd?

As of October 31, 2026, the Gayatri BioOrganics Ltd stock price is INR ₹8.0. On the other hand, Prima Innovation Ltd stock price is INR ₹24.8.

How do dividend payouts of Gayatri BioOrganics Ltd and Prima Innovation Ltd compare?

To compare the dividend payouts of Gayatri BioOrganics Ltd and Prima Innovation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.